Temporal changes in FFR
Aged
Computed Tomography Angiography
/ trends
Coronary Angiography
/ trends
Coronary Artery Disease
/ diagnostic imaging
Coronary Stenosis
/ diagnostic imaging
Coronary Vessels
/ diagnostic imaging
Europe
Female
Fractional Flow Reserve, Myocardial
Humans
Japan
Male
Middle Aged
North America
Practice Patterns, Physicians'
/ trends
Predictive Value of Tests
Prospective Studies
Referral and Consultation
/ trends
Registries
Time Factors
Treatment Outcome
Angina
Computerized tomography
Coronary artery disease
Fractional flow reserve
Ischemia
Journal
Journal of cardiovascular computed tomography
ISSN: 1876-861X
Titre abrégé: J Cardiovasc Comput Tomogr
Pays: United States
ID NLM: 101308347
Informations de publication
Date de publication:
Historique:
received:
28
11
2019
revised:
09
04
2020
accepted:
27
04
2020
pubmed:
19
5
2020
medline:
7
4
2021
entrez:
19
5
2020
Statut:
ppublish
Résumé
The ADVANCE registry is a large prospective study of outcomes and resource utilization in patients undergoing coronary computed tomography angiography (CCTA) and CT-based fractional flow reserve (FFR 5083 patients with coronary artery disease (CAD) on CCTA were prospectively enrolled in the ADVANCE registry and were divided into 3 equally sized cohorts based on the temporal order of enrollment per site. Demographics, CCTA and FFR The number of patients with a ≥70% stenosis on CCTA was similar over time (33.6%, 30.9%, and 33.8% for cohort 1-3). The rate of positive FFR Growing experience with FFR
Sections du résumé
BACKGROUND
BACKGROUND
The ADVANCE registry is a large prospective study of outcomes and resource utilization in patients undergoing coronary computed tomography angiography (CCTA) and CT-based fractional flow reserve (FFR
METHODS
METHODS
5083 patients with coronary artery disease (CAD) on CCTA were prospectively enrolled in the ADVANCE registry and were divided into 3 equally sized cohorts based on the temporal order of enrollment per site. Demographics, CCTA and FFR
RESULTS
RESULTS
The number of patients with a ≥70% stenosis on CCTA was similar over time (33.6%, 30.9%, and 33.8% for cohort 1-3). The rate of positive FFR
CONCLUSIONS
CONCLUSIONS
Growing experience with FFR
Identifiants
pubmed: 32418861
pii: S1934-5925(20)30143-X
doi: 10.1016/j.jcct.2020.04.011
pii:
doi:
Types de publication
Journal Article
Multicenter Study
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
48-55Informations de copyright
Copyright © 2020 Society of Cardiovascular Computed Tomography. Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest Dr. Nous has received travel sponsorship from HeartFlow. Dr. Fairbairn has served on the Speakers Bureau for HeartFlow. Dr. Nørgaard has received unrestricted institutional research grants from Siemens and HeartFlow. Dr. Berman has received unrestricted research support from HeartFlow. Dr. Hurwitz-Koweek has received research support and fee as speaker from HeartFlow and Siemens. Dr. Pontone has received research grant and/or fee as speaker from GE Healthcare, Bracco, and HeartFlow. Dr. Budde has institutional research support from HeartFlow and Siemens Healthineers. Dr. Sonck has received research grant support from the Cardiopath PhD program. Dr. Rabbat has served as a consultant for HeartFlow. Dr. Mullen is an employee of and owns equity in HeartFlow. Dr. De Bruyne has received consulting fees from Abbott, Opsens, and Boston Scientific; and is a shareholder for Siemens, GE Healthcare, Bayer, Philips, HeartFlow, Edwards Lifesciences, and Sanofi. Dr. Rogers is employee of and owns equity in HeartFlow. Dr. Leipsic has served as a consultant for and owns stock options in Circle CVI and HeartFlow. Dr. Patel has received research grants from HeartFlow, Bayer, Janssen, and the National Heart, Lung, and Blood Institute; and has served on the advisory board for HeartFlow, Bayer, and Janssen. Dr. Nieman has received institutional research support from Siemens Healthineers, HeartFlow, GE Healthcare, and Bayer Healthcare. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.